SEATTLE (AP) — SEATTLE (AP) — Adaptive Biotechnologies Corp. (ADPT) on Wednesday reported third-quarter profit of $2.9 million.

The Seattle-based company said it had profit of 2 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 10 cents per share.

The life-sciences research company posted revenue of $83.9 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $71.8 million.

Adaptive Biotechnologies shares have increased 64% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $26.71, a rise of 58% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADPT at https://www.zacks.com/ap/ADPT